Citations

Showing 10 of 108119 citations.

How a Virtual Scribe Program Improves Physicians’ EHR Experience, Documentation Time, and Note Quality
Ong, S. , Williams, Brian , O’Connell, Ryan , Goldstein, Richard , Melnick, Edward R. , Melnick, Edward R , Jeffery, Molly Moore

Mayo Clinic

NEJM Catalyst | November 17, 2021 | Volume: 2 | Issue: 12 | Pages: No page available

10.1056/cat.21.0294 Get It

Preoperative echocardiography as a prognostic tool for liver transplant in patients with hypertrophic cardiomyopathy
Pai, Sher‐Lu , Logvinov, Ilana I. , Brigham, Tara , Watt, Kymberly D. , Palmer, William C. , Blackshear, Joseph L., Aniskevich, Stephen , Li, Zhuo , Brigham, T J , Palmer, William C , Aniskevich, Stephen , Pai, Sher-Lu , Logvinov, Ilana , Chadha, Ryan , Li, Zhuo

Mayo Clinic

Clinical Transplantation | November 17, 2021 | Volume: 36 | Issue: 2 | Pages: No page available

10.1111/ctr.14538 | PMID 34787329 Get It

AbstractBackgroundHypertrophic cardiomyopathy (HCM) presents with a hypertrophied left ventricle (LV). It is often associated with LV outflow tract obstruction (LVOTO) and a risk for sudden death. This study aimed to describe outcomes of patients with HCM who underwent liver transplant (LT).MethodsA retrospective review was conducted for patients diagnosed with HCM undergoing LT. Patient characteristics, preoperative echocardiography results, HCM risk of sudden cardiac death prediction model score, and 5‐year mortality were examined. A univariable Cox proportional hazards model was used to evaluate the association between risk factors and 5‐year mortality. All tests were two‐sided with the alpha level set at .05.ResultsTwenty‐nine patients were included in the analysis. Six patients (21%) had a perioperative cardiopulmonary complication. The 5‐year survival rate was 61% (95% CI, 45–82). The analyzed risk factors showed that 5‐year post‐LT survival was significantly predicted by maximal LV outflow tract gradient at rest > 60 mmHg (hazard ratio, 1.04 [95% CI, 1.01‐1.06]).ConclusionsPreoperative LV outflow tract resting gradient > 60 mmHg was associated with 5‐year post‐LT mortality. The results suggest the severity of LVOTO identified by echocardiography is a prognostic tool for patients with HCM after LT.
Recognizing Unmet Need in the Era of Targeted Therapy for CLL/SLL: “What's Past Is Prologue” (Shakespeare)
Mato, Anthony R. , Sharman, Jeff P. , Kay, Neil E. , Kater, Arnon P. , Rogers, Kerry A. , Rhodes, Joanna , Skarbnik, Alan P , Eyre, Toby A. , Nabhan, Chadi , Lamanna, Nicole , Pagel, John M. , Ujjani, Chaitra S. , Brander, Danielle M. , Coombs, Catherine C. , Cheah, Chan Y. , Brown, Jennifer R. , Seymour, John F. , Woyach, Jennifer A. , Sharman, Jeff , Kay, Neil E , Rogers, Kerry A , Rhodes, Joanna , Eyre, Toby A , Sun, Clare , Cheah, Chan Yoon , Seymour, John F , Davids, Matthew S. , Roeker, Lindsey E. , Thompson, Meghan C , Goy, Andre Henri , Schuster, Stephen J. , Tam, Constantine S. , O’Brien, Susan , Shadman, Mazyar , Jain, Nitin

Mayo Clinic

Clinical Cancer Research | November 17, 2021 | Volume: 28 | Issue: 4 | Pages: 603-608

10.1158/1078-0432.ccr-21-1237 | PMID 34789482 Get It

Abstract The management of chronic lymphocytic leukemia (CLL) has undergone unprecedented changes over the last decade. Modern targeted therapies are incorporated into clinical practice. Unfortunately, patients have begun to develop resistance or intolerance to multiple classes. Symptomatic patients previously treated with a BTK inhibitor (BTKi) and venetoclax represent a new and rapidly growing unmet need in CLL. Here, we define unmet needs in a modern treatment context. We also critically review the literature for PI3K inhibitors and chemoimmunotherapy and lack of data to support their utility following BTKis and venetoclax. Finally, we suggest opportunities to ensure the continued innovation for patients with CLL.
Association of Neutrophil-to-Lymphocyte Ratio with Efficacy of First-Line Avelumab plus Axitinib vs. Sunitinib in Patients with Advanced Renal Cell Carcinoma Enrolled in the Phase 3 JAVELIN Renal 101 Trial
Bilen, Mehmet Asım , Voss, Martin H. , Larkin, James , Albigès, Laurence , Pagliaro, Lance C. , Voog, Éric , Kislov, Nikolay , Lalani, Aly‐Khan A. , Huang, Bo , Pietro, Alessandra di , Krulewicz, Stan , Robbins, Paul B. , Choueiri, Toni K. , Voss, Martin H , Kislov, Nikolay , McGregor, Bradley , Lalani, Aly-Khan A , Huang, Bo , Krulewicz, Stan , Choueiri, Toni K , Rini, Brian I. , Haanen, John B A G , Lam, Elaine T. , McGregor, Bradley A.

Mayo Clinic

Clinical Cancer Research | November 17, 2021 | Volume: 28 | Issue: 4 | Pages: 738-747

10.1158/1078-0432.ccr-21-1688 | PMID 34789480 Get It

Abstract Purpose: To evaluate the association between neutrophil-to-lymphocyte ratio (NLR) and efficacy of avelumab plus axitinib or sunitinib. Experimental Design: Adult patients with untreated advanced renal cell carcinoma (RCC) with a clear-cell component, ≥1 measurable lesions, Eastern Cooperative Oncology Group performance status of 0 or 1, fresh or archival tumor specimen, and adequate renal, cardiac, and hepatic function were included. Retrospective analyses of the association between baseline NLR and progression-free survival (PFS) and overall survival (OS) in the avelumab plus axitinib or sunitinib arms were performed using the first interim analysis of the phase 3 JAVELIN Renal 101 trial (NCT02684006). Multivariate Cox regression analyses of PFS and OS were conducted. Translational data were assessed to elucidate the underlying biology associated with differences in NLR. Results: Patients with below-median NLR had longer observed PFS with avelumab plus axitinib [stratified HR, 0.85; 95% confidence interval (CI), 0.634–1.153] or sunitinib (HR, 0.56; 95% CI, 0.415–0.745). In the avelumab plus axitinib or sunitinib arms, respectively, median PFS was 13.8 and 11.2 months in patients with below-median NLR, and 13.3 and 5.6 months in patients with median-or-higher NLR. Below-median NLR was also associated with longer observed OS in the avelumab plus axitinib (HR, 0.51; 95% CI, 0.300–0.871) and sunitinib arms (HR, 0.30; 95% CI, 0.174–0.511). Tumor analyses showed an association between NLR and key biological characteristics, suggesting a role of NLR in underlying mechanisms influencing clinical outcome. Conclusions: Current data support NLR as a prognostic biomarker in patients with advanced RCC receiving avelumab plus axitinib or sunitinib.
Commentary on Significance of Monoclonal Band in Cerebral Spinal Fluid
Willrich, Maria Alice V. , Willrich, Maria A

Mayo Clinic

Clinical Chemistry | November 17, 2021 | Volume: 68 | Issue: 2 | Pages: 281-281

10.1093/clinchem/hvab255 | PMID 35104858 Get It

Ex Vivo and In Vivo CD46 Receptor Utilization by Species D Human Adenovirus Serotype 26 (HAdV26)
Hemsath, Jack R. , Liaci, A. Manuel , Rubin, Jeffrey D. , Parrett, Brian J. , Lu, Shao‐Chia , Turner, Mallory A., Chen, Christopher Y. , Cupelli, Karolina, Reddy, Vijay , Stehle, Thilo , Liszewski, M. Kathryn , Atkinson, John P. , Barry, Michael A. , Stehle, Thilo , Barry, Michael A , Nguyen, Tien Anh

Mayo Clinic

Journal of Virology | November 17, 2021 | Volume: 96 | Issue: 3 | Pages: No page available

10.1128/jvi.00826-21 | PMID 34787457 Get It

The human species D Ad26 is being investigated as a low-seroprevalence vector for oncolytic virotherapy and gene-based vaccination against HIV-1 and SARS-CoV-2. However, there is debate in the literature about its tropism and receptor utilization, which directly influence its efficiency for certain applications. This work was aimed at determining which receptor(s) this virus uses for infection and its role in virus biology, vaccine efficacy, and, importantly, vaccine safety.
Nonsedated Magnetic Resonance Imaging for Visualization of the Velopharynx in the Pediatric Population
Kotlarek, Katelyn J. , Sitzman, Thomas J. , Chee-Williams, Jessica L. , Perry, Jamie L. , Sitzman, Thomas J , Chee-Williams, Jessica L , Perry, Jamie L

Mayo Clinic

The Cleft Palate Craniofacial Journal | November 17, 2021 | Volume: 60 | Issue: 2 | Pages: 249-252

10.1177/10556656211057361 | PMID 34787476 Get It

Background Non-sedated MRI is gaining traction in clinical settings for visualization of the velopharynx in children with velopharyngeal insufficiency. However, the behavioral adaptation and training aspects that are essential for successful pediatric MRI have received limited attention. Solution We outline a program of behavioral modifications combined with patient education and provider training that has led to high success rates for non-sedated velopharyngeal MRI in children.
CyberEye: New Eye-Tracking Interfaces for Assessment and Modulation of Cognitive Functions beyond the Brain
Lech, Michał , Czyżewski, Andrzej , Kucewicz, Michał T.

Mayo Clinic

Sensors | November 17, 2021 | Volume: 21 | Issue: 22 | Pages: 7605

10.3390/s21227605 | PMID 34833681 Get It

The emergence of innovative neurotechnologies in global brain projects has accelerated research and clinical applications of BCIs beyond sensory and motor functions. Both invasive and noninvasive sensors are developed to interface with cognitive functions engaged in thinking, communication, or remembering. The detection of eye movements by a camera offers a particularly attractive external sensor for computer interfaces to monitor, assess, and control these higher brain functions without acquiring signals from the brain. Features of gaze position and pupil dilation can be effectively used to track our attention in healthy mental processes, to enable interaction in disorders of consciousness, or to even predict memory performance in various brain diseases. In this perspective article, we propose the term ‘CyberEye’ to encompass emerging cognitive applications of eye-tracking interfaces for neuroscience research, clinical practice, and the biomedical industry. As CyberEye technologies continue to develop, we expect BCIs to become less dependent on brain activities, to be less invasive, and to thus be more applicable.
Clinical Predictors of Mortality in Prehospital Distress Calls by Emergency Medical Service Subscribers
Elbaz‐Greener, Gabby , Carasso, Shemy , Gallimidi, Lior, Yarkoni, Merav , Abend, Yitzhak, Dagan, Yinon, Amir, Offer, Maor, Elad , Wijeysundera, Harindra C. , Lerman, Amir

Mayo Clinic

Journal of Clinical Medicine | November 17, 2021 | Volume: 10 | Issue: 22 | Pages: 5355

10.3390/jcm10225355 | PMID 34830638 Get It

(1) Introduction: Most studies rely on in-hospital data to predict cardiovascular risk and do not include prehospital information that is substantially important for early decision making. The aim of the study was to define clinical parameters in the prehospital setting, which may affect clinical outcomes. (2) Methods: In this population-based study, we performed a retrospective analysis of emergency calls that were made by patients to the largest private emergency medical services (EMS) in Israel, SHL Telemedicine Ltd., who were treated on-site by the EMS team. Demographics, clinical characteristics, and clinical outcomes were analyzed. Mortality was evaluated at three time points: 1, 3, and 12 months’ follow-up. The first EMS prehospital measurements of the systolic blood pressure (SBP) were recorded and analyzed. Logistic regression analyses were performed. (3) Results: A total of 64,320 emergency calls were included with a follow-up of 12 months post index EMS call. Fifty-five percent of patients were men and the mean age was 70.2 ± 13.1 years. During follow-up of 12 months, 7.6% of patients died. Age above 80 years (OR 3.34; 95% CI 3.03–3.69, p < 0.005), first EMS SBP ≤ 130 mm Hg (OR 2.61; 95% CI 2.36–2.88, p < 0.005), dyspnea at presentation (OR 2.55; 95% CI 2.29–2.83, p < 0001), and chest pain with ischemic ECG changes (OR 1.95; 95% CI 1.71–2.23, p < 0.001) were the highest predictors of 1 month mortality and remained so for mortality at 3 and 12 months. In contrast, history of hypertension and first EMS prehospital SBP ≥ 160 mm Hg were significantly associated with decreased mortality at 1, 3 and 12 months. (4) Conclusions: We identified risk predictors for all-cause mortality in a large cohort of patients during prehospital EMS calls. Age over 80 years, first EMS-documented prehospital SBP < 130 mm Hg, and dyspnea at presentation were the most profound risk predictors for short- and long-term mortality. The current study demonstrates that in prehospital EMS call settings, several parameters can be used to improve prioritization and management of high-risk patients.
Anterior Shoulder Instability in Throwers and Overhead Athletes: Long-term Outcomes in a Geographic Cohort
Wilbur, Ryan R. , Shirley, Matthew B., Nauert, Richard F. , LaPrade, Matthew D. , Okoroha, Kelechi R. , Krych, Aaron J. , Krych, Aaron J , Camp, Christopher L.

Mayo Clinic

The American Journal of Sports Medicine | November 17, 2021 | Volume: 50 | Issue: 1 | Pages: 182-188

10.1177/03635465211059195 | PMID 34786982 Get It

Background: Athletes of all sports often have shoulder instability, most commonly as anterior shoulder instability (ASI). For overhead athletes (OHAs) and those participating in throwing sports, clinical and surgical decision making can be difficult owing to a lack of long-term outcome studies in this population of athletes. Purpose/Hypothesis: To report presentation characteristics, pathology, treatment strategies, and outcomes of ASI in OHAs and throwers in a geographic cohort. We hypothesized that OHAs and throwers would have similar presenting characteristics, management strategies, and clinical outcomes but lower rates of return to play (RTP) when compared with non-OHAs (NOHAs) and nonthrowers, respectively. Study Design: Cohort study; Level of evidence, 3. Methods: An established geographic medical record system was used to identify OHAs diagnosed with ASI in the dominant shoulder. An overall 57 OHAs with ASI were matched 1:2 with 114 NOHAs with ASI. Of the OHAs, 40 were throwers. Sports considered overhead were volleyball, swimming, racquet sports, baseball, and softball, while baseball and softball composed the thrower subgroup. Records were reviewed for patient characteristics, type of sport, imaging findings, treatment strategies, and surgical details. Patients were contacted to collect Western Ontario Shoulder Instability index (WOSI) scores and RTP data. Statistical analysis compared throwers with nonthrowers and OHAs with NOHAs. Results: Four patients, 3 NOHAs and 1 thrower, were lost to follow-up at 6 months. Clinical follow-up for the remaining 167 patients (98%) was 11.9 ± 7.2 years (mean ± SD). Of the 171 patients included, an overall 41 (36%) NOHAs, 29 (51%) OHAs, and 22 (55%) throwers were able to be contacted for WOSI scores and RTP data. OHAs were more likely to initially present with subluxations (56%; P = .030). NOHAs were more likely to have dislocations (80%; P = .018). The number of instability events at presentation was similar. OHAs were more likely to undergo initial operative management. Differences in rates of recurrent instability were not significant after initial nonoperative management (NOHAs, 37.1% vs OHAs, 28.6% [ P = .331] and throwers, 21.2% [ P = .094]) and surgery (NOHAs, 20.5% vs OHAs, 13.0% [ P = .516] and throwers, 9.1% [ P = .662]). Rates of revision surgery were similar (NOHAs, 18.0% vs OHAs, 8.7% [ P = .464] and throwers, 18.2% [ P > .999]). RTP rates were 80.5% in NOHAs, as compared with 71.4% in OHAs ( P = .381) and 63.6% in throwers ( P = .143). Median WOSI scores were 40 for NOHAs, as compared with 28 in OHAs ( P = .425) and 28 in throwers ( P = .615). Conclusion: In a 1:2 matched comparison of general population athletes, throwers and OHAs were more likely to have more subtle instability, as evidenced by higher rates of subluxations rather than frank dislocations, when compared with NOHAs. Despite differences in presentation and the unique sport demands of OHAs, rates of recurrent instability and revision surgery were similar across groups. Similar outcomes in terms of RTP, level of RTP, and WOSI scores were achieved for OHAs and NOHAs, but these results must be interpreted with caution given the limited sample size.